Weight-loss drugs can improve kidney health, study finds

"The findings suggest that GLP-1 receptor agonists not only assist with weight loss but also significantly reduce the risk of worsening kidney function and kidney-related mortality."

"Our extensive meta-analysis revealed a 19% overall reduction in the risk of kidney failure, worse kidney function, and death from kidney disease among users of GLP-1 receptor agonists."

Read at www.theguardian.com